Secondary Immunodeficiency and Risk of Infection Following Immune Therapies in Neurology-Reference-Cited by-同舟云学术

Secondary Immunodeficiency and Risk of Infection Following Immune Therapies in Neurology

Published:2021-10-16 Issue:11 Volume:35 Page:1173-1188
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Szepanowski Fabian,Warnke Clemens,Meyer zu Hörste Gerd,Mausberg Anne K.,Hartung Hans-Peter,Kleinschnitz Christoph,Stettner Mark

Funder

Octapharma provided a grant for writing the article. Octapharma did not have any influence on the contents for which the authors are entirely responsible.

Universitätsklinikum Essen

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)

Link

https://link.springer.com/content/pdf/10.1007/s40263-021-00863-4.pdf

Reference130 articles.

1. McCusker C, Upton J, Warrington R. Primary immunodeficiency. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):61.

2. Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27(5):497–502.

3. Aiello A, Farzaneh F, Candore G, Caruso C, Davinelli S, Gambino CM, et al. Immunosenescence and Its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention. Front Immunol. 2019;10:2247.

4. Patel SY, Carbone J, Jolles S. The expanding field of secondary antibody deficiency: causes, diagnosis, and management. Front Immunol. 2019;10:33.

5. Friman V, Winqvist O, Blimark C, Langerbeins P, Chapel H, Dhalla F. Secondary immunodeficiency in lymphoproliferative malignancies. Hematol Oncol. 2016;34(3):121–32.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity;Vaccines;2024-06-18

2. Antibiotic failure: Beyond antimicrobial resistance;Drug Resistance Updates;2023-11

3. Could Immune Checkpoint Disorders and EBV Reactivation Be Connected in the Development of Hematological Malignancies in Immunodeficient Patients?;Cancers;2023-09-29

4. Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management;Journal of Neurology;2023-09-07

5. Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method;Therapeutic Advances in Neurological Disorders;2023-01